<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="191243-2018"
            EDITION="2018085">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-195634-001</RECEPTION_ID>
      <DELETION_DATE>20180605</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>85</NO_OJ>
         <DATE_PUB>20180503</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 085-191243</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:191243-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="UK"/>
         <IA_URL_GENERAL>https://nhsengland.bravosolution.co.uk</IA_URL_GENERAL>
         <IA_URL_ETENDERING>https://nhsengland.bravosolution.co.uk</IA_URL_ETENDERING>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="UKK">SOUTH WEST (ENGLAND)</n2016:PERFORMANCE_NUTS>
         <n2016:PERFORMANCE_NUTS CODE="UKJ">SOUTH EAST (ENGLAND)</n2016:PERFORMANCE_NUTS>
         <n2016:PERFORMANCE_NUTS CODE="UKI">LONDON</n2016:PERFORMANCE_NUTS>
         <n2016:PERFORMANCE_NUTS CODE="UKG">WEST MIDLANDS (ENGLAND)</n2016:PERFORMANCE_NUTS>
         <n2016:PERFORMANCE_NUTS CODE="UKF">EAST MIDLANDS (ENGLAND)</n2016:PERFORMANCE_NUTS>
         <n2016:PERFORMANCE_NUTS CODE="UKE">YORKSHIRE AND THE HUMBER</n2016:PERFORMANCE_NUTS>
         <n2016:PERFORMANCE_NUTS CODE="UKD">NORTH WEST (ENGLAND)</n2016:PERFORMANCE_NUTS>
         <n2016:PERFORMANCE_NUTS CODE="UKC">NORTH EAST (ENGLAND)</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="UK">UNITED KINGDOM</n2016:CA_CE_NUTS>
         <VALUES>
            <VALUE TYPE="ESTIMATED_TOTAL" CURRENCY="GBP">227000000</VALUE>
         </VALUES>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180501</DS_DATE_DISPATCH>
         <DT_DATE_FOR_SUBMISSION>20180605 13:00</DT_DATE_FOR_SUBMISSION>
         <AA_AUTHORITY_TYPE CODE="1">Ministry or any other national or federal authority</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="3">Contract notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="1">Submission for all lots</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B02</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Обединено кралство</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Spojené království/Velká Británie</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Forenede Kongerige, Det</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>das Vereinigte Königreich</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Ηνωμένο Βασίλειο</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>United Kingdom</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Suurbritannia / Ühendkuningriik</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Yhdistynyt kuningaskunta</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Royaume-Uni</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Ríocht Aontaithe, an</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Ujedinjena Kraljevina</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Egyesült Királyság</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Regno Unito</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Jungtinė Karalystė, Didžioji Britanija</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Apvienotā Karaliste</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Ir-Renju Unit</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Verenigd Koninkrijk</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Zjednoczone Królestwo</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Regatul Unit</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Spojené kráľovstvo</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Združeno kraljestvo</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Förenade kungariket</TI_CY>
            <TI_TOWN>Cheshire</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">NHS Commissioning Board (operating under the name of NHS England)</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F02_2014 CATEGORY="ORIGINAL" FORM="F02" LG="EN">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>NHS Commissioning Board (operating under the name of NHS England)</OFFICIALNAME>
               <ADDRESS>NHS England, Rutland House Second Floor, Runcorn</ADDRESS>
               <TOWN>Cheshire</TOWN>
               <POSTAL_CODE>WA7 2ES</POSTAL_CODE>
               <COUNTRY VALUE="UK"/>
               <E_MAIL>michelle.clarke6@nhs.net</E_MAIL>
               <n2016:NUTS CODE="UK"/>
               <URL_GENERAL>https://nhsengland.bravosolution.co.uk</URL_GENERAL>
               <URL_BUYER>https://nhsengland.bravosolution.co.uk</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <DOCUMENT_FULL/>
            <URL_DOCUMENT>https://nhsengland.bravosolution.co.uk</URL_DOCUMENT>
            <ADDRESS_FURTHER_INFO_IDEM/>
            <URL_PARTICIPATION>https://nhsengland.bravosolution.co.uk</URL_PARTICIPATION>
            <ADDRESS_PARTICIPATION_IDEM/>
            <CA_TYPE VALUE="MINISTRY"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>NHS Framework agreement for Trastuzumab injection</P>
            </TITLE>
            <REFERENCE_NUMBER>CM/PHR/18/5566</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>NHS Framework agreement for Trastuzumab injection.</P>
               <P>Offer reference number: CM/PHR/18/5566.</P>
               <P>Period of framework agreement:</P>
               <P>CM/PHR/18/5566/01 – NHS framework agreement for Trastuzumab injection for Midlands and East and North of England - 16.7.2018 – 28.2.2019 with an option to extend (at the authority’s discretion) for a period or periods up to a total of 12 months.</P>
               <P>CM/PHR/18/5566/02 – NHS framework agreement for Trastuzumab injection for London and South of England – 16.7.2018 – 31.8.2019 with an option to extend (at the authority’s discretion) for a period or periods up to a total of 12 months.</P>
            </SHORT_DESCR>
            <VAL_ESTIMATED_TOTAL CURRENCY="GBP">227000000</VAL_ESTIMATED_TOTAL>
            <LOT_DIVISION>
               <LOT_ALL/>
            </LOT_DIVISION>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>Midlands and East and North of England</P>
               </TITLE>
               <LOT_NO>1</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="UKC"/>
               <n2016:NUTS CODE="UKD"/>
               <n2016:NUTS CODE="UKE"/>
               <n2016:NUTS CODE="UKF"/>
               <n2016:NUTS CODE="UKG"/>
               <MAIN_SITE>
                  <P>Please refer to Schedule 8 of the framework agreement document nº 03 in the ITO documents for the list of purchasing points.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Products associated with the lots are listed on document n<FT TYPE="SUP">o</FT> 05 of the invitation to offer.</P>
                  <P>Each individual National Product Code (NPC) pack description in each of the regions is deemed to be a separate product for the application of the award criteria.</P>
                  <P>There is no restriction on the number of products that bidders can offer for, or be awarded.</P>
                  <P>The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England.</P>
                  <P>The framework may also be used by private sector contractors and agents working on behalf of the above.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-07-16</DATE_START>
               <DATE_END>2019-02-28</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>London and South of England</P>
               </TITLE>
               <LOT_NO>2</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="UKI"/>
               <n2016:NUTS CODE="UKJ"/>
               <n2016:NUTS CODE="UKK"/>
               <MAIN_SITE>
                  <P>Please refer to Schedule 8 of the framework agreement document nº 03 in the ITO.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Products associated with the lots are listed on Document No 05a of the Invitation to offer each individual National Product Code (NPC) pack description in each of the regions is deemed to be a separate product for the application of the award criteria.</P>
                  <P>There is no restriction on the number of products that bidders can offer for, or be awarded.</P>
                  <P>The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England.</P>
                  <P>The framework may also be used by private sector contractors and agents working on behalf of the above.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-07-16</DATE_START>
               <DATE_END>2019-08-31</DATE_END>
               <NO_RENEWAL/>
               <ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK>
               <SEVERAL_OPERATORS/>
            </FRAMEWORK>
            <CONTRACT_COVERED_GPA/>
            <DATE_RECEIPT_TENDERS>2018-06-05</DATE_RECEIPT_TENDERS>
            <TIME_RECEIPT_TENDERS>13:00</TIME_RECEIPT_TENDERS>
            <LANGUAGES>
               <LANGUAGE VALUE="EN"/>
            </LANGUAGES>
            <OPENING_CONDITION>
               <DATE_OPENING_TENDERS>2018-06-05</DATE_OPENING_TENDERS>
               <TIME_OPENING_TENDERS>13:00</TIME_OPENING_TENDERS>
               <PLACE>
                  <P>Runcorn</P>
               </PLACE>
               <INFO_ADD>
                  <P>Commercial medicines unit employee.</P>
               </INFO_ADD>
            </OPENING_CONDITION>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <NO_RECURRENT_PROCUREMENT/>
            <EORDERING/>
            <EINVOICING/>
            <EPAYMENT/>
            <INFO_ADD>
               <P>Responding to this notice. Any supplier may be disqualified who does not respond to the following in the requisite manner:</P>
               <P>1) submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at: www.nhsengland.bravosolution.co.uk</P>
               <P>Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:</P>
               <P>1.1) If not already registered, candidates should register on the eTendering portal at:</P>
               <P>https://www.nhsengland.bravosolution.co.uk and click the link to register: accept the terms and conditions and click “continue”, enter your correct business and user details, note the username you chose and click “save” when complete, you will shortly receive an email with your unique password (please keep this secure).</P>
               <P>1.2) Once registered, candidates must express interest as follows:</P>
               <P>a— login to the eTendering portal,</P>
               <P>b— select response to ITT,</P>
               <P>c— select ITTs open to all suppliers,</P>
               <P>d— access listing related to this procurement NHS Framework agreement - Trastuzumab injection and view details,</P>
               <P>e— click on Express interest button at the top of the page,</P>
               <P>f— once you have expressed interest, the ITT will move to My ITTs, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the Publish button.</P>
               <P>1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk at +44 800 368 4850 or: help@bravosolution.co.uk</P>
               <P>2) General supplier information. To manage and assess supplier information the contracting authority requests candidates provide their company profile in the Governments supplier information database, sid4gov, as follows:</P>
               <P>2.1) If not already registered, candidates must go to the following web page: https://sid4gov.cabinetoffice.gov.uk/ and select Register for sid4gov at the bottom of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&amp;B. Candidates must obtain a Dun &amp; Bradstreet (D&amp;B) D-U-N-S® Number to enable registration on sid4gov.</P>
               <P>2.2) Once registration is complete you are able to create and update your sid4gov company profile. Candidates should ensure all the mandatory fields of their sid4gov profile are completed and up to date for each procurement exercise. D&amp;B data will be supplied automatically by D&amp;B.</P>
               <P>2.3) For further help or information concerning sid4gov, please contact the sid4gov Helpdesk at: support@nqc.com or telephone +44 (0) 845 299 2994.</P>
               <P>The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other Government departments or non-departmental public bodies charged with the delivery of healthcare or health related services. Variants: An Offerer is permitted to submit any number of variants to the authority.</P>
               <P>(subject to the minimum requirements set out in the ITO Terms of Offer Document 2, paragraph 8.2.1.</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>The NHS Commissioning Board (Operating Under the Name of NHS England)</OFFICIALNAME>
               <TOWN>Runcorn</TOWN>
               <POSTAL_CODE>WA7 2ES</POSTAL_CODE>
               <COUNTRY VALUE="UK"/>
            </ADDRESS_REVIEW_BODY>
            <DATE_DISPATCH_NOTICE>2018-05-01</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F02_2014>
   </FORM_SECTION>
</TED_EXPORT>
